Beckley Psytech logo

Beckley Psytech

Transforming psychedelics into effective and rapid-acting medicines for neuropsychiatric conditions.

68 employees · est. 2019 · Oxford, United Kingdom

VS
Gilgamesh Pharmaceuticals logo

Gilgamesh Pharmaceuticals

33 employees · est. 2019 · New York, United States

Beckley Psytech is the larger of the two.

Side-by-Side Comparison

Beckley Psytech Gilgamesh Pharmaceuticals
Founded
2019 2019
Headquarters
Oxford, United Kingdom New York, United States
Employees
68 larger 33
Industry
Not tracked yet Biotechnology, Health Care, Pharmaceutical
Funding Stage
Merged Grant
Total Funding
$114.55M $82.56M
Funding Rounds
5 7
Services
Developing mental health treatments, Conducting clinical trials, Empathy-driven patient care Not tracked yet
Target Customers
Individuals with mental health conditions, Healthcare providers, Investors interested in mental health solutions Not tracked yet
Taxonomy
Psychedelic Medicine, Neuropsychiatric Disorders, Clinical-stage, Psilocybin, Drug Development, Mental Health Treatment, Rapid-acting Medicines, Depression Treatment, Scientific Research, Therapeutic Potential, Modern Medical Practice, Patient Outcomes Optimization, Beckley Foundation Research Biotech, Clinical-stage Biotech, Mental Health Treatment, Novel Compounds, Psychedelics, Drug Development, Mental Illness, Therapeutic Innovation, NCEs, Safety Optimization, Efficacy Optimization, Patient Access, Durable Therapies, Clinical Trials, Innovation
Website
beckleypsytech.com gilgameshpharmaceutical.com
Beckley Psytech logo

About Beckley Psytech

Beckley Psytech is a pioneering, clinical-stage biotechnology company founded in 2019 and headquartered in the United Kingdom. With a clear mission of "Transforming psychedelics into effective and rapid-acting medicines for neuropsychiatric conditions," the company is focused on leveraging decades o...

Gilgamesh Pharmaceuticals logo

About Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals is a clinical-stage biotech company founded in 2019 in the United States. The company's vision is to reshape how mental illnesses are treated, focusing on rapid-acting and durable therapies targeting the fundamental drivers of disease rather than symptom management. Gilgame...

We will tell you when either one moves

BounceWatch watches Beckley Psytech and Gilgamesh Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Beckley Psytech and Gilgamesh Pharmaceutic... — by email.

Frequently Asked Questions

Beckley Psytech — Transforming psychedelics into effective and rapid-acting medicines for neuropsychiatric conditions.. Gilgamesh Pharmaceuticals. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Beckley Psytech has raised $114.55M while Gilgamesh Pharmaceuticals has raised $82.56M.
Beckley Psytech and Gilgamesh Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Beckley Psytech with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Beckley Psytech on 9 Apr 2026, and Gilgamesh Pharmaceuticals on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy